Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
United States
Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston, Massachusetts Last updated February 2026